Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Designing a children's health exposomics study protocol: The CHILDREN_FIRST multi-country prospective cohort using multi-omics and personalized prevention approaches

  • Konstantinou, Cristina
  • Guxens Junyent, Mònica
  • Makris, Konstantinos C.
Non-communicable diseases (NCDs) account for ~71% of all deaths globally, including 15 million premature deaths each year (deaths between 30-69 years of age). Instead of waiting until disease manifestation, focusing on the origins of NCDs during childhood offers a critical window of disease prevention and control. The CHILDREN_FIRST international cohort observatory study aims to investigate how the spatio-temporal evolution of the children's exposome profiles in the Mediterranean region influences early-life programming of chronic disease risk during the critical window of susceptibility in primary school years (6-11 years of age). The study protocol adopts the human exposome framework integrated with a personalized prevention approach, using multi-omics platforms and advanced machine learning algorithms implemented across Mediterranean countries, namely Cyprus, Greece, and Albania. The cohort will consist of children enrolled in the first grade of primary school, who will undergo annual follow-up assessments until completion of primary education. During the annual assessments, children's exposome parameters from the three main exposome domains will be evaluated using different assessment types, i.e., molecular biomarkers of exposure/effect, sensors, and questionnaires. Standardized biospecimen and data collection methods will be employed following harmonized standardized operating procedures. The reference model of Observational Medical Outcomes Partnership - Common Data Model (OMOP-CDM) developed and maintained as part of the Observational Health Data Sciences and Informatics (OHDSI) initiative will be used to conduct federated data analysis. This CHILDREN_FIRST study protocol is a human exposome-based initiative to establish a long-term prospective cohort infrastructure for biomedical research on children's health in the Mediterranean region. The cohort's exposome-based findings will systematically feed into the evaluation and design of chronic disease prevention programs. Expected results would inform evidence-based policy making and the development of health interventions for reducing the risk of NCDs in childhood and later in adult life., This research received start-up funds from internal funds in Cyprus (KCM). KCM received funding from the H2020 IHEN project with grant agreement ID: 101137317. ISGlobal (MG) acknowledge support from the grant CEX2023-0001290-S funded by MCIN/AEI/ 10.13039/501100011033, and support from the Generalitat de Catalunya through the CERCA Program. The biobank.cy Center of Excellence which hosts the Biobank of Cyprus is funded through the CY-Biobank, which is an EU Horizon 2020 Research and Innovation Programme under Grant Agreement no. 857122, the Republic of Cyprus, and the University of Cyprus (CD). This research was supported by two commercial entities: PHOEBE Research and Innovation LTD (GM, AK) and CP. Food Lab (LE), which provided financial support in the form of salaries for authors GM, AK, LE and research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Designing a children's health exposomics study protocol: The CHILDREN_FIRST multi-country prospective cohort using multi-omics and personalized prevention approaches

  • Konstantinou, Cristina
  • Guxens Junyent, Mònica
  • Makris, Konstantinos C.
Non-communicable diseases (NCDs) account for ~71% of all deaths globally, including 15 million premature deaths each year (deaths between 30-69 years of age). Instead of waiting until disease manifestation, focusing on the origins of NCDs during childhood offers a critical window of disease prevention and control. The CHILDREN_FIRST international cohort observatory study aims to investigate how the spatio-temporal evolution of the children's exposome profiles in the Mediterranean region influences early-life programming of chronic disease risk during the critical window of susceptibility in primary school years (6-11 years of age). The study protocol adopts the human exposome framework integrated with a personalized prevention approach, using multi-omics platforms and advanced machine learning algorithms implemented across Mediterranean countries, namely Cyprus, Greece, and Albania. The cohort will consist of children enrolled in the first grade of primary school, who will undergo annual follow-up assessments until completion of primary education. During the annual assessments, children's exposome parameters from the three main exposome domains will be evaluated using different assessment types, i.e., molecular biomarkers of exposure/effect, sensors, and questionnaires. Standardized biospecimen and data collection methods will be employed following harmonized standardized operating procedures. The reference model of Observational Medical Outcomes Partnership - Common Data Model (OMOP-CDM) developed and maintained as part of the Observational Health Data Sciences and Informatics (OHDSI) initiative will be used to conduct federated data analysis. This CHILDREN_FIRST study protocol is a human exposome-based initiative to establish a long-term prospective cohort infrastructure for biomedical research on children's health in the Mediterranean region. The cohort's exposome-based findings will systematically feed into the evaluation and design of chronic disease prevention programs. Expected results would inform evidence-based policy making and the development of health interventions for reducing the risk of NCDs in childhood and later in adult life., This research received start-up funds from internal funds in Cyprus (KCM). KCM received funding from the H2020 IHEN project with grant agreement ID: 101137317. ISGlobal (MG) acknowledge support from the grant CEX2023-0001290-S funded by MCIN/AEI/ 10.13039/501100011033, and support from the Generalitat de Catalunya through the CERCA Program. The biobank.cy Center of Excellence which hosts the Biobank of Cyprus is funded through the CY-Biobank, which is an EU Horizon 2020 Research and Innovation Programme under Grant Agreement no. 857122, the Republic of Cyprus, and the University of Cyprus (CD). This research was supported by two commercial entities: PHOEBE Research and Innovation LTD (GM, AK) and CP. Food Lab (LE), which provided financial support in the form of salaries for authors GM, AK, LE and research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The 2019 and 2021 International Workshops on Alport Syndrome

  • Daga, Sergio
  • Ding, Jie
  • Savige, Judy|||0000-0002-6813-0288
  • Lipska-Ziętkiewicz, Beata S.|||0000-0002-4169-9685
  • Hoefele, Julia|||0000-0002-7917-7129
  • Flinter, Frances
  • Gale, Daniel|||0000-0002-9170-1579
  • Aksenova, Marina|||0000-0002-3699-1884
  • Kai, Hirofumi
  • Perin, Laura
  • Barua, Moumita
  • Torra Balcells, Roser|||0000-0001-8714-2332
  • Miner, Jeff H.|||0000-0002-1510-8714
  • Massella, Laura|||0000-0001-5796-3965
  • Ljubanović, Danica Galešić
  • Lennon, Rachel|||0000-0001-6400-0227
  • Weinstock, Andrè B.
  • Knebelmann, Bertrand
  • Cerkauskaite, Agne
  • Gear, Susie
  • Gross, Oliver|||0000-0002-8390-8852
  • Turner, A. Neil|||0000-0003-4547-873X
  • Baldassarri, Margherita
  • Pinto, Anna Maria|||0000-0001-6259-6901
  • Renieri, Alessandra|||0000-0002-0846-9220
In 1927 Arthur Cecil Alport, a South African physician, described a British family with an inherited form of kidney disease that affected males more severely than females and was sometimes associated with hearing loss. In 1961, the eponymous name Alport syndrome was adopted. In the late twentieth century three genes responsible for the disease were discovered: COL4A3, COL4A4, and COL4A5 encoding for the α3, α4, α5 polypeptide chains of type IV collagen, respectively. These chains assemble to form heterotrimers of type IV collagen in the glomerular basement membrane. Scientists, clinicians, patient representatives and their families, and pharma companies attended the 2019 International Workshop on Alport Syndrome, held in Siena, Italy, from October 22 to 26, and the 2021 online Workshop from November 30 to December 4. The main topics included: disease re-naming, acknowledging the need to identify an appropriate term able to reflect considerable clinical variability; a strategy for increasing the molecular diagnostic rate; genotype-phenotype correlation from monogenic to digenic forms; new therapeutics and new therapeutic approaches; and gene therapy using gene editing. The exceptional collaborative climate that was established in the magical medieval setting of Siena continued in the online workshop of 2021. Conditions were established for collaborations between leading experts in the sector, including patients and drug companies, with the aim of identifying a cure for Alport syndrome.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Correction, The 2019 and 2021 International workshops on Alport syndrome

  • Daga, Sergio
  • Ding, Jie
  • Deltas, Constantinos|||0000-0001-5549-9169
  • Savige, Judy|||0000-0002-6813-0288
  • Lipska-Ziętkiewicz, Beata S.|||0000-0002-4169-9685
  • Hoefele, Julia|||0000-0002-7917-7129
  • Flinter, Frances
  • Gale, Daniel|||0000-0002-9170-1579
  • Aksenova, Marina|||0000-0002-3699-1884
  • Kai, Hirofumi
  • Perin, Laura
  • Barua, Moumita
  • Torra Balcells, Roser|||0000-0001-8714-2332
  • Miner, Jeff H.|||0000-0002-1510-8714
  • Massella, Laura|||0000-0001-5796-3965
  • Ljubanović, Danica Galešić
  • Lennon, Rachel|||0000-0001-6400-0227
  • Weinstock, Andrè B.
  • Knebelmann, Bertrand
  • Cerkauskaite, Agne
  • Gear, Susie
  • Gross, Oliver|||0000-0002-8390-8852
  • Turner, A. Neil|||0000-0003-4547-873X
  • Baldassarri, Margherita
  • Pinto, Anna Maria|||0000-0001-6259-6901
  • Renieri, Alessandra|||0000-0002-0846-9220